Surgical treatment of ischemic heart disease in patients with diabetes
https://doi.org/10.21886/2219-8075-2017-8-4-23-27
Abstract
It is known that coronary atherosclerosis has more severe consequences if there is a patient of diabetes, as the combination of these two factors signifi cantly increases the risk of manifestations of CHD, oft en combined with prolonged atherosclerotic plaques in the coronary artery, multivessel coronary artery disease, lesions of the left coronary artery. In this regard, an increasing number of patients are becoming candidates for a revascularization of a myocardium. Despite signifi cant advances in endovascular surgery, the results of coronary stenting in diabetic patients remain worse than in CHD patients without diabetes. Th e results of large-scale studies testify to the undoubted benefi ts of carrying out coronary artery bypass graft ing (CABG) in diabetic patients, with their characteristic multi-vessel lesion of coronary arteries
About the Authors
Roman V. Sidorov
Rostov State Medical University
Russian Federation
PhD, associate Professor of the surgical diseases chair №2
Russian Federation
PhD, associate Professor of the surgical diseases chair №2
Egor P. Talalaev
Rostov State Medical University
Russian Federation
post-graduate student of the surgical diseases chair №2
Russian Federation
post-graduate student of the surgical diseases chair №2
Vitaly N. Shchetko
Rostov State Medical University
post-graduate student of the surgical diseases chair №2
post-graduate student of the surgical diseases chair №2
Irina F. Shlyk
Rostov regional clinical hospital
PhD
PhD
Olga L. Eroshenko
Rostov State Medical University
PhD, assistent professor, Department of Ultrasound Diagnostics of the Faculty of Training and Retraining of Specialists
PhD, assistent professor, Department of Ultrasound Diagnostics of the Faculty of Training and Retraining of Specialists
References
1. Akchurin RS, Vlasova EE, Mershin KV. Diabetus mellitus and surgical treatment of coronary heart disease. Vestnik RAMN. 2012;(1):14-19. (In Russ).
2. Silva JA, Escobar A, Collins TJ, Ramee SR, White CJ. Unstable angina: a comparison of angioscopic fi ndings between diabetic and non-diabetic patients. Circulation. 1995;92(7):1731–36.
3. Rask-Madsen C, King GL. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pract. Endocrinol. Metab. 2007;3(1):46–56. doi: 10.1038/ncpendmet0366
4. Sidorov RV, Petyaev AA, Petyaev AM, Pospelov DY, Doltmurzieva NS, Shchetko VN. Temporary interluminal shunting under conditions of a parallel cardiopulmonary bypass. Meditsinskii vestnik yuga Rossii. 2016;(1):72-76. (in Russ.)
5. BARI Investigators. Th e fi nal 10-year follow-up results from the BARI randomized trial. J. Am. Coll. Cardiol. 2007;49(15):1600–6. doi: 10.1016/j.jacc.2006.11.048
6. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients. Th e National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94(8):1818–25.
7. Brooks ММ, Jones RН, Bach RG, Chaitman BR, Kern MJ, Orszulak TA, et al. Predictors of mortality and mortality from cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial and Registry. Circulation. 2000;101(23):2682–2689.
8. .Feher МD, Elkeles RS. Lipid modifi cation and соronary heart disease in type 2 diabetes: diff erent the general population. Heart.1999;81:10–11.
9. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431.
10. Weintraub WS, Stein B, Kosinski А, Douglas JS Jr, Ghazzal ZM, Jones EL, et al. Outcome of coronary bypass surgery versus соronarу angioplasty in diabetic patients with multivessel coronary artery disease. JACC. 1998;31:10–19.
11. Timmis АD. Diabetes. Brit. Med. 2001;59:159–172.
12. Legrand VM, Serruys PW, Unger F, van Hout BA, Vrolix MC, Fransen GM, et al. Th ree-year outcome aft er coronary stenting versus bypass surgery for the treatment of multivessel disease. Ibid. 2004;109(9):1114–1120. doi: 10.1161/01.CIR.0000118504.61212.4B
13. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schönberger JP, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344(15):1117-24. doi: 10.1056/NEJM200104123441502
14. Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, Kolm P, et al. Comparative effectiveness of revascularization strategies. N. Engl. J. Med. 2012;366(16):1467–76. doi: 10.1056/NEJMoa1110717
15. Kappetein P, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur. J. Cardiothorac. Surg. 2013;43(5):1006–13. doi: 10.1093/ejcts/ezt017
16. Banning AP, Westaby S, Morice MC, Kappetein AP, Mohr FW, Berti S, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease comparison of outcomes with cardiac surgery and paclitaxeleluting stents. J. Am. Coll. Cardiol. 2010;55(11):1067–75. doi: 10.1016/j.jacc.2009.09.057
17. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J. 2003;24:987–1003.
18. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N. Engl. J. Med. 2012;367(25):2375–84. doi: 10.1056/NEJMoa1211585
Review
For citations:
Sidorov R.V., Talalaev E.P., Shchetko V.N., Shlyk I.F., Eroshenko O.L. Surgical treatment of ischemic heart disease in patients with diabetes. Medical Herald of the South of Russia. 2017;8(4):23-27. (In Russ.) https://doi.org/10.21886/2219-8075-2017-8-4-23-27
Views:
1473
Email this article 